Sigma Foods (SIGMAF) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Double-digit EBITDA growth in Q2 and H1 2024, led by Sigma's record performance and operational efficiencies, with Alpek contributing through cost initiatives and savings.
Sigma achieved its 13th consecutive quarter of year-on-year revenue growth and an all-time high quarterly EBITDA, supported by strong demand and favorable FX.
Alpek completed a $75M annualized savings plan and continued cost competitiveness efforts, offsetting industry headwinds.
2024 guidance for both Sigma and consolidated results was raised, reflecting robust H1 performance and better-than-expected results.
Strategic focus on deleveraging, asset monetization, and transformation to enable Alpek's separation and unlock value.
Financial highlights
Consolidated revenues reached $4,221 million in Q2 2024, up from $4,197 million in Q1 2024.
Q2 2024 EBITDA was $445 million, up 23% year-over-year and 5% sequentially; Sigma's Q2 EBITDA reached a historic high of $279 million.
Alpek's accumulated comparable EBITDA of $312 million is on track for full-year guidance, with a 2% volume increase in H1, mainly from polyester.
Net debt decreased by $117 million in Q2 2024 compared to Q1 2024, with Sigma's net leverage ratio at 2.0x, the lowest in nearly 11 years.
Alpek's leverage ratio improved to 3.3x, with 5% lower net debt quarter-on-quarter and strong cash flow from reduced CapEx, dividends, and working capital optimization.
Outlook and guidance
2024 consolidated EBITDA guidance raised 5% to $1.59 billion, and revenues up 1% to $16.78 billion, with Sigma accounting for 62% of the new guidance.
Sigma's 2024 revenue guidance raised to $8.85 billion and EBITDA to $1.0 billion, up 2% and 9% from original projections.
Alpek's 2024 EBITDA guidance maintained at $600 million, targeting year-end net debt/EBITDA of 2.5x and no dividend payment in 2024.
Latest events from Sigma Foods
- Record 4Q25 EBITDA, strong innovation, and sustainability progress drive growth outlook.SIGMAF
Corporate presentation25 Feb 2026 - Record 2025 results and Alpek spin-off set up strong 2026 growth and higher dividends.SIGMAF
Q4 202512 Feb 2026 - Sigma posts record EBITDA as ALFA advances Alpek spin-off and targets lower leverage.SIGMAF
Q3 202418 Jan 2026 - Record results and transformation position for growth as Alpek spin-off nears completion.SIGMAF
Q4 202419 Dec 2025 - Record revenues and sequential EBITDA gains despite cost and operational headwinds.SIGMAF
Q3 202514 Dec 2025 - Transformation complete, 1Q25 EBITDA at US$220M, S&P upgrades to 'BBB'.SIGMAF
Q1 202529 Nov 2025 - Record 2Q25 revenues and EBITDA, with insurance gains and strategic transformation completed.SIGMAF
Q2 202513 Nov 2025